- Home
- FRO vs BLLN Comparison
FRO vs BLLN Comparison
Compare FRO & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRO | BLLN |
|---|---|---|
| Founded | 1985 | 2016 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.0B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | FRO | BLLN |
|---|---|---|
| Price | $21.51 | $87.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $28.67 | ★ $137.83 |
| AVG Volume (30 Days) | ★ 3.4M | 209.0K |
| Earning Date | 11-21-2025 | 12-09-2025 |
| Dividend Yield | ★ 8.15% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | ★ $1,766,241,000.00 | $254,136,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.53 | N/A |
| P/E Ratio | $22.35 | ★ N/A |
| Revenue Growth | N/A | ★ 254.30 |
| 52 Week Low | $12.40 | $88.00 |
| 52 Week High | $26.00 | $138.70 |
Technical Indicators
Market Signals| Indicator | FRO | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | N/A |
| Support Level | $21.69 | N/A |
| Resistance Level | $22.08 | N/A |
| Average True Range (ATR) | 0.50 | 0.00 |
| MACD | -0.16 | 0.00 |
| Stochastic Oscillator | 10.55 | 0.00 |
Price Performance
Historical ComparisonAbout FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.
About BLLN BillionToOne Inc.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.